斯帕丰和山莨菪碱治疗痉挛性腹痛的临床研究  

Clinical Research of Treatment for Spasfon and Anisodamine on Spastic Bellyache

作　　者：王颖彦[1] 常瑞明[2] 温立强[2] 林华[1] 

机构地区：[1]广东省中医院药学部临床药学室,510120 [2]中山大学附属第二医院急诊科

出　　处：《岭南急诊医学杂志》2009年第3期188-189,共2页Lingnan Journal of Emergency Medicine

摘　　要：目的:探讨斯帕丰对痉挛性腹痛的治疗效果及可能机制。方法:将216例痉挛性腹痛的患者随机分为斯帕丰组(112例)和对照组(104例),分别采用斯帕丰与山莨菪碱治疗,观察患者的解痉止痛效果及其不良反应。结果:斯帕丰组有效率为91.12%,山莨菪碱组为89.36%,无显著差异性(P>0.05),但副反应明显低于山莨菪碱组(P<0.01)。结论:斯帕丰治疗痉挛性腹痛疗效确切,而且副反应少。Objective:To investigate the therapeutic efficacy and possible mechanism of Spasfon on spastic bellyache.Methods:216 patients suffering from spastic bellyache were divided into Spasfon group (n=112)and Anisodamine group (n=104).The patients were respectively treated by Spasfon and Anisodamine.The therapeutic efficacy and side effects were observed.Results:The effective rate of Spasfon group was 91.12%,and that of Anisodamine group was 89.36%.The two groups have no significant difference (P>0.05).The side effect of Spasfon group was less than that of the Anisodamine(P<0.01).Conclusions:Spasfon has evident curative effect and low side effects to the spastic bellyache.

关 键 词：斯帕丰 痉挛性腹痛 疗效 

分 类 号：R57[医药卫生—消化系统]